Abstract: A dual pocket or envelope for CDs or DVDs is formed of two standard letter size sheets of 8½?×11? or A-4 size paper, which are bonded together around the edges of the sheets and centrally to divide the sheet assembly into two pockets which are substantially square to hold the discs. One of the sheets is die cut to form the upper edge of the pockets, with a closure flap also being formed above each pocket. Each closure flap may be held in the closed position by mechanical interlinking with the pocket, or by exposed pressure sensitive adhesive, which is enabled and exposed by the removal of a release coated slip of paper from one of the two sheets. An index tab may be die cut from said sheets above the open edge of each pocket.

Abstract: A top dressing for seedling containers which consists of particles of expanded polystyrene having a density of not less than 10 pounds per cubic foot and not more than 3 5 pounds per cubic foot. It is preferred that the top dressing be made by recycling used seedling containers.

Abstract: Ultraremovable adhesive is applied to a paper sheet to form therewith a liner sheet and the liner sheet is laminated to a cardstock sheet to form a laminate cardstock. The cardstock sheet is then die cut therethrough, but not through the liner sheet, to form cardstock cut lines that define at least in part perimeters of business cards (or other printable media). The outer face of the liner sheet is then die cut therethrough, but not through the cardstock sheet, to form liner sheet strips on a back side of the cardstock sheet. Some of the strips define cover strips covering some of the cardstock cut lines, and others of the strips define waste strips. The waste strips are then matrix removed from the back of the cardstock sheet. The resulting business card sheet construction is then fed through a printer or copier by the user and the desired indicia printed on the front sides of the business cards, while the cover strips hold the cards together as a unit sheet construction.

Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.

Abstract: Compounds are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, including stroke.

Abstract: An article for holding a liquefied sample for the quantification of biological material in the sample includes a device having a reaction chamber enclosing a volume therein, the reaction chamber having an upper opening through which a liquefied sample can be poured and a plurality of discrete non-permeable compartments, each of the compartments having an upper rim and being configured and dimensioned to hold separate aliquots of a liquefied sample therein; and a gasket lid removably secured to the top of the device, the gasket lid being configured and dimensioned for sealing the upper rim of each compartment to prevent liquid communication between the compartments.

Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.

Abstract: This invention concerns compounds of formula 1

Abstract: This invention concerns compounds of formula 1

Abstract: This invention concerns compounds of formula 1

Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.

Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.

Abstract: Compounds are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, including stroke. The compounds of this invention have the following structures: wherein n, m, R, R1, R2, X and Ar are as defined herein, including stereoisomes and pharmaceutically acceptable salts thereof.

Abstract: Surgical instruments and methods are provided. In one aspect, a method of securing a fixation device within an opening in a tissue is provided, including delivering a material in a flowable state to said opening, and changing the state of the material so that the material forms an interference fit that secures the fixation device in the opening.

Abstract: This invention relates to certain novel 2′-halomethylidene, 2′-ethenylidene and 2′-ethynyl cytidine, uridine and guanosine derivatives, and compositions thereof, which are useful in the treatment of patients afflicted with neoplastic or viral disease states.

Abstract: A dual pocket or envelope for CDs or DVDs is formed of two standard letter size sheets of 8½″×11″ or A-4 size paper, which are bonded together around the edges of the sheets and centrally to divide the sheet assembly into two pockets which are substantially square to hold the discs. One of the sheets is die cut to form the upper edge of the pockets, with a closure flap also being formed above each pocket. Each closure flap may be held in the closed position by mechanical interlinking with the pocket, or by exposed pressure sensitive adhesive, which is enabled and exposed by the removal of a release coated slip of paper from one of the two sheets. An index tab may be die cut from said sheets above the open edge of each pocket.

Abstract: A surgical device includes a return electrode, an active electrode, and an insulating region adjacent to the active electrode. A rasping surface is provided by either the active electrode or the insulating region. Another surgical device includes an adapter configured to couple to a generator and to convert monopolar output from the generator into bipolar output. A method of applying electricity to tissue includes bringing a surgical device into close proximity with tissue and applying electricity to the tissue using the surgical device.

Abstract: A method of printing a certificate purchased online, such as a printed ticket, directions, a food coupon, a parking pass, a merchandise coupon or other types of certificates, may include purchasing at least one certificate across a computer network and printing the certificate onto the media using a desktop printer. The media may be a sheet having a plurality of separate printing areas separated by lines of weakness. In one embodiment of the media, a sheet has equally-sized printing areas separated into rows and columns by lines of weakness. In another embodiment of the invention, a consumer purchases one or more tickets across a computer network, and then prints the ticket or tickets using a desktop printer. The ticket may be printed onto a media having a ticket printing area defined on at least one edge by a line of weakness.

Abstract: This invention concerns compounds of formula including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R1 is NR4R5 or OR5; R2 is C1-6alkyl, C1-6alkyloxy or C1-6alkylthio; R3 is hydrogen, C1-6alkyl, C1-6alkylsulfonyl, C1-6alkylsulfoxy or C1-6alkylthio; R4 is hydrogen, C1-6alkyl, mono- or di(C3-6cycloalkyl)methyl, C3-6cycloalkyl, C3-6alkenyl, hydroxyC1-6alkyl, C1-6alkylcarbonyloxyC1-6alkyl or C1-6alkyloxyC1-6alkyl; R5 is C1-6alkyl, mono- or di(C3-6cycloalkyl)methyl, Ar1CH2, C1-6alkyloxyC1-6alkyl, hydroxyC1-6alkyl, C3-6alkenyl, thienylmethyl, furanylmethyl, C1-6alkylthioC1-6alkyl, morpholinyl, mono- or di(C1-6alkyl)aminoC1-6alkyl, di(C1-6alkyl)amino, C1-6alkylcarbonylC1-6alkyl, C1-6alkyl substituted with imidazolyl; or a radical of formula —Alk—O—CO—Ar1; or R4 and R5 taken together with the nitrogen atom to which they are attached may form an optionally substituted pyrrolidinyl, piperidinyl, homopiperidinyl or morpholinyl g

Abstract: This invention concerns compounds of formula including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R1 is C1-6alkyl, NR5R6, OR6 or SR6; R2 is C1-6alkyl, C1-6alkyloxy, or C1-6alkylthio; R3 is Ar1 or Het1; R4 is hydrogen or C1-6alkyl; R5 is hydrogen, C1-8alkyl, mono- or di(C3-6cycloalkyl)methyl, C3-6cycloalkyl, C3-6alkenyl, hydroxyC1-6alkyl, C1-6alkylcarbonyloxyC1-6alkyl, mono- or di(C1-6alkyl)amino-C1-6alkyl or C1-6alkyloxyC1-6alkyl; R6 is C1-8alkyl, mono- or di(C3-6cycloalkyl)methyl, Ar2C1-6alkyl, Ar2oxyC1-6alkyl, C1-6alkyloxyC1-6alkyl, hydroxyC1-6alkyl, C3-6alkenyl, thienylmethyl, furanylmethyl, tetrahydrofuranylmethyl, C1-6alkylthioC1-6alkyl, mono- or di(C1-6alkyl)aminoC1-6alkyl, di(C1-6alkyl)amino, or C1-6alkylcarbonylC1-6alkyl; or R5 and R6 taken together with the nitrogen atom to which they are attached may form a pyrrolidinyl, piperidinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl group, optionally substituted with 1 or 2 substi